A federal judge sentenced a medical clinic owner and a pharmacy technician for their involvement in a clinical trial fraud scheme that included the falsification and fabrication of clinical trial …
Topic:
clinical
-
-
By Natalie Grover and Martin Coulter LONDON (Reuters) – Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed …
-
By Bhanvi Satija and Mariam Sunny (Reuters) – Shares of Sage Therapeutics slumped to a record low on Monday after the U.S. health regulator approved the company and partner Biogen’s …
-
By Deena Beasley (Reuters) -In a mid-stage trial, the highest dose of Eli Lilly’s experimental pill orforglipron led to 14.7% weight loss after 36 weeks for people who were obese …
-
Two Clinical Labs and Their Owners Agree to Pay $5.7 Million to Resolve False Claims and Kickback Allegations
by DOJ PressNEWARK, N.J. – Two clinical laboratories and their owners have agreed to pay $5.7 million to resolve allegations that they caused the submission of false claims to Medicare by paying …
-
Salix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL’s International Liver Congress™ 2022
by Your NewsLAVAL, QC, June 20, 2022 — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its gastroenterology business, Salix Pharmaceuticals, (“Salix”), one of the largest specialty pharmaceutical companies in the …
-
(Reuters) – Walgreens Boots Alliance Inc on Thursday launched a clinical trials business that aims to use patient data from its pharmacies to help drive up recruitment in studies conducted …
-
Jubilant Therapeutics Inc. annonce le développement d’inhibiteurs de PD-L1 à petite molécule, disponibles par voie orale et pénétrant dans le cerveau, lors de la réunion annuelle 2022 de l’American Society of Clinical Oncology (ASCO) France – Français USA – English
by Your NewsBEDMINSTER, N.J., 3 juin 2022 — Jubilant Therapeutics Inc., une société de thérapies de précision au stade clinique qui fait progresser les petites molécules thérapeutiques pour répondre à des besoins …
-
Jubilant Therapeutics Inc. annonce le développement d’inhibiteurs de PD-L1 à petite molécule, disponibles par voie orale et pénétrant dans le cerveau, lors de la réunion annuelle 2022 de l’American Society of Clinical Oncology (ASCO) France – Français USA – English Deutschland – Deutsch
by Your NewsBEDMINSTER, N.J., 3 juin 2022 — Jubilant Therapeutics Inc., une société de thérapies de précision au stade clinique qui fait progresser les petites molécules thérapeutiques pour répondre à des besoins …
-
Jubilant Therapeutics Inc. berichtet auf der Jahrestagung 2022 der American Society of Clinical Oncology (ASCO) über die Entwicklung oral verfügbarer und ins Gehirn eindringender niedermolekularer PD-L1-Inhibitoren Deutschland – Deutsch USA – English France – Français
by Your NewsBEDMINSTER, N.J., 3. Juni 2022 — Jubilant Therapeutics Inc., ein Unternehmen für Präzisionstherapeutika in der klinischen Phase, das niedermolekulare Therapeutika für ungedeckten medizinischen Bedarf in der Onkologie und bei Autoimmunerkrankungen …
-
Androvia LifeSciences Presented Data, Providing Scientific Insights that Support Clinical Utility of Cap-Score™, a Validated and Consistent Measure of Fertility
by Your NewsResearch presented at 47th Annual Conference of the American Society of Andrology (ASA) demonstrates ability of Cap-Score Test to measure and predict a man’s fertility LA JOLLA, Calif., May 16, …
-
(Reuters) – Nektar Therapeutics said on Thursday it had stopped all trials involving its key cancer drug following its failure in multiple studies, dragging the drug developer’s shares down 23% in …
-
Local/N.J. Doctor Selected as one of 30 members nationwide to the athenahealth 2022 Clinical Advisory Board Dr. Dan Fabius, Consensus Health Chief Medical Informatics Officer will collaborate with the athenahealth product team
by Your News“I am honored to join this incredible team of experts and believe our collaborative efforts will greatly impact the future of athenahealth products to better serve doctors and patients in …
-
Brookdale Premier Addiction Recovery Announces Jennifer Russo as Chief Clinical Officer
by Your News“Jenny is a talented, innovative leader with integrity and passion for cultivating talent.” Tweet this Russo attended graduate school at Centenary College, now known as Centenary University, where she received …
-
Mitsubishi Tanabe Pharma America Highlights ALS Research at 2022 MDA Clinical & Scientific Conference
by Your NewsJERSEY CITY, N.J., March 11, 2022 — Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that five presentations on amyotrophic lateral sclerosis (ALS) will be shared as part of the …
-
GARDEN GROVE, Calif. and MARLTON, N.J., March 8, 2022 — Apex Innovative Sciences (“Apex” or the “Company”), a leading provider of clinical development and trial site services, is pleased to …
-
A Florida woman pleaded guilty today to obstructing a 2017 regulatory inspection in connection with an alleged scheme to fraudulently falsify clinical drug trial data. According to court documents, Olga …
-
A Colorado man pleaded guilty today in connection with his participation in a scheme to falsify clinical drug trial data. Duniel Tejeda, 35, of Canon City, Colorado, and formerly of …